Moderna (MRNA)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-01 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Moderna, Inc. (MRNA) CIK: 0001682852 --- Reporting Owner --- Name: Klinger Shannon Thyme CIK: 0001866132 Role: Officer (Chief Legal Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-09-01 | Code: M (Exercise of derivative) Shares: +3,471 | Price: $30.96 Total Value: $107,462.16 Shares Owned After: 77,600 | Ownership: D (Direct) Footnotes: [F1] The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025. [Transaction #2] Security: Common Stock Date: 2026-09-01 | Code: S (Open market sale) Shares: -3,471 | Price: $139.95 Total Value: $485,766.45 Shares Owned After: 74,129 | Ownership: D (Direct) Footnotes: [F1] The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025. [Transaction #3] Security: Common Stock Date: 2026-09-01 | Code: M (Exercise of derivative) Shares: +2,166 Shares Owned After: 76,295 | Ownership: D (Direct) Footnotes: [F2] Restricted stock units convert into common stock on a one-for-one basis. [F2] Restricted stock units convert into common stock on a one-for-one basis. [Transaction #4] Security: Common Stock Date: 2026-09-01 | Code: F (Payment of exercise/tax) Shares: -1,048 | Price: $140.34 Total Value: $147,076.32 Shares Owned After: 75,247 | Ownership: D (Direct) Footnotes: [F3] Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. --- Derivative Transactions --- [Transaction #1] Security: Stock Option (Right to Buy) Date: 2026-09-01 | Code: M (Exercise of derivative) Shares: -3,471 | Price: $0.00 Exercise Price: $30.96 Exercisable: N/A | Expires: 2035-03-01 Shares Owned After: 34,716 | Ownership: D (Direct) Footnotes: [F1] The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025. [F4] 25% of this option vested and became exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. [Transaction #2] Security: Restricted Stock Units Date: 2026-09-01 | Code: M (Exercise of derivative) Shares: -2,166 | Price: $0.00 Shares Owned After: 21,661 | Ownership: D (Direct) Footnotes: [F2] Restricted stock units convert into common stock on a one-for-one basis. [F2] Restricted stock units convert into common stock on a one-for-one basis. [F5] 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. [F5] 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. --- Footnotes (Complete Index) --- F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025. F2: Restricted stock units convert into common stock on a one-for-one basis. F3: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F4: 25% of this option vested and became exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F5: 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. --- Signature --- /s/ /s/ James Dillon, as Attorney-in-Fact (2026-09-03)